Key result
Knockdown of lncRNA OIP5-AS1 attenuates nonylphenol-induced myocardial fibrosis and collagen deposition in preclinical models.
Why the study?
Environmental endocrine disruptors like nonylphenol may affect heart diseases via epigenetics, and lncRNA mediates endocrine disruptor-induced heart cell damage and fibrosis.
p-value: p=0.001
Knockdown of lncRNA OIP5-AS1 attenuates nonylphenol-induced cardiac fibrosis, suggesting it as a potential therapeutic target for environmental endocrine disruptor-induced myocardial fibrosis.
Hypothesis-generating for NP-related cardiac fibrosis; leaves open human relevance of EED-lncRNA pathways.
Background: Environmental endocrine disruptors (EEDs), endocrine-interfering pollutants, attract attention for potentially affecting heart diseases via epigenetics. Nonylphenol (NP), a classical representative of endocrine-disrupting chemicals, has previously been demonstrated by our research group to induce myocardial fibrosis in rats. LncRNA, a gene regulator, mediates EED-induced heart cell damage and fibrosis.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied Myocardial fibrosis (n=40). lncRNA OIP5-AS1 knockdown (AAV9-sh-OIP5-AS1) vs. Nonylphenol exposure alone was evaluated on Collagen deposition (Masson and Sirius Red staining) (p=0.001). Knockdown of lncRNA OIP5-AS1 significantly attenuated nonylphenol-induced myocardial fibrosis and reduced collagen deposition in both H9C2 cells and rat models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: